GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 73 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $238,426 | -32.8% | 138,620 | -23.8% | 0.00% | 0.0% |
| Q2 2023 | $354,771 | -31.7% | 181,934 | -2.7% | 0.00% | -50.0% |
| Q1 2023 | $519,677 | -19.4% | 186,934 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $644,923 | +34.4% | 186,934 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $480,000 | +42.9% | 186,934 | +34.5% | 0.00% | +50.0% |
| Q2 2022 | $336,000 | -25.7% | 138,947 | +26.5% | 0.00% | -33.3% |
| Q1 2022 | $452,000 | -56.3% | 109,800 | +36.4% | 0.00% | -57.1% |
| Q4 2021 | $1,035,000 | +73.9% | 80,500 | +46.1% | 0.01% | +40.0% |
| Q3 2021 | $595,000 | +202.0% | 55,100 | +155.1% | 0.01% | +150.0% |
| Q2 2021 | $197,000 | +99.0% | 21,600 | +105.7% | 0.00% | +100.0% |
| Q1 2021 | $99,000 | -66.9% | 10,500 | -86.2% | 0.00% | -75.0% |
| Q4 2020 | $299,000 | -3.2% | 75,884 | -33.9% | 0.00% | -20.0% |
| Q3 2020 | $309,000 | -59.4% | 114,884 | -1.2% | 0.01% | -61.5% |
| Q2 2020 | $761,000 | +28.8% | 116,254 | +11.9% | 0.01% | 0.0% |
| Q1 2020 | $591,000 | +79.6% | 103,854 | +156.7% | 0.01% | +160.0% |
| Q4 2019 | $329,000 | – | 40,454 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $17,536,000 | 1.82% |
| EcoR1 Capital, LLC | 3,421,287 | $13,480,000 | 0.72% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $8,123,000 | 0.63% |
| BVF INC/IL | 2,695,418 | $10,620,000 | 0.42% |
| Column Group LLC | 869,493 | $3,426,000 | 0.31% |
| Avidity Partners Management LP | 2,122,064 | $8,361,000 | 0.27% |
| Redmile Group, LLC | 3,059,794 | $12,056,000 | 0.15% |
| SkyOak Wealth, LLC | 69,778 | $275,000 | 0.09% |
| Tekla Capital Management LLC | 419,005 | $1,651,000 | 0.06% |
| Blackstone Inc. | 2,567,445 | $10,116,000 | 0.04% |